CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 368 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03495869
NCT03495869N/ACompleted
CompareCT.gov

NIDA Phenotyping Assessments Battery (PhAB) Feasibility and Validation Study in Non-Intoxicated Drug Users

Virginia Commonwealth University·observational·Posted Apr 12, 2018·Updated Aug 4, 2021

In Brief

An observational study for Opioid-use Disorder and 3 related conditions. Completed, enrolled 368 participants across 1 site.

Detailed Summary

The overall goal of this project is to collect preliminary data on psychosocial measures and behavioral performance comparing individuals with Opioid Use Disorder, Cocaine Use Disorder, dual diagnosis of Opioid and Cocaine Use Disorder, and Healthy Controls in an effort to determine overall feasibility of a phenotypic "fingerprint" for cohorts of individuals with addictions for use during clinical trials.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid-use Disorder, Cocaine Use Disorder, Marijuana Use Disorder, Healthy Controls
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 12, 2018
Enrollment StartJun 21, 2018
Primary CompletionMar 16, 2020
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.2 years ago